ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Quality of Life for Males With Abdominal Aortic Aneurysm.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Abdominal aortic aneurysm (AAA), with rupture as the major consequence, is a life-threatening disease. Although screening programs for AAA reduce mortality, it is unclear how a diagnosis impacts quality of life (QoL) in males. This study sought to measure the change in QoL for males with AAA at baseline and after 12 months. Methods: Between January 1, 2019, and February 28, 2022, males with AAA completed the 12-item short form health survey version 2 (SF-12v2) at baseline and after 12 months. SF-12v2 measures general health, physical functioning, role limitations, bodily pain, vitality, social functioning, role-emotional, and mental health. Clinical risk factors including age, race, body mass index, diabetes, hypertension, hyperlipidemia, coronary artery disease, cerebrovascular accident, myocardial infarction, and smoking status were also collected. Results: Ninety-one patients with an AAA were followed in a vascular clinic and completed the SF-12v2. The mean (SD) age was 76.0 (5.6) years and body mass index was 29.7 (6.4). The change in SF-12v2 scores from baseline to 12 months showed statistically significant improvement in QoL for general health ( Conclusions: After 12 months, males with AAA reported statistically significant higher QoL scores in general health and bodily pain. These results suggest the need for periodic QoL assessments to track changes over time for males with AAA.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.